Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
5(31%)
Results Posted
33%(2 trials)
Terminated
1(6%)

Phase Distribution

Ph early_phase_1
1
6%
Ph not_applicable
1
6%
Ph phase_2
7
44%
Ph phase_3
1
6%

Phase Distribution

1

Early Stage

7

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
Phase 2Efficacy & side effects
7(70.0%)
Phase 3Large-scale testing
1(10.0%)
N/ANon-phased studies
1(10.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

5

trials recruiting

Total Trials

16

all time

Status Distribution
Active(6)
Completed(6)
Terminated(2)
Other(2)

Detailed Status

Completed6
Recruiting3
Active, not recruiting2
unknown2
Withdrawn1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
5
Success Rate
85.7%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (10.0%)
Phase 27 (70.0%)
Phase 31 (10.0%)
N/A1 (10.0%)

Trials by Status

withdrawn16%
active_not_recruiting213%
recruiting319%
unknown213%
enrolling_by_invitation16%
completed638%
terminated16%

Recent Activity

Clinical Trials (16)

Showing 16 of 16 trials
NCT05876390

Impact of Regional Anesthesia on Chronic Post-operative Pain

Enrolling By Invitation
NCT03546686Phase 2

Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer

Active Not Recruiting
NCT06291064Phase 2

Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer

Recruiting
NCT04854005

Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation

Active Not Recruiting
NCT06635980Phase 2

Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer

Recruiting
NCT05919108Phase 2

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

Recruiting
NCT01805076Phase 3

MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer

Completed
NCT04805736Phase 2

Microwave Ablation Combined With Camrelizumab in the Treatment of Early Breast Cancer

Completed
NCT04866147

Prediction of Chronic Postsurgical Pain in Adults

Completed
NCT06070324Not Applicable

Effect of Suture Material on Postoperative Nipple Areolar Complex Widening

Unknown
NCT01980823Early Phase 1

Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer

Completed
NCT05604677

Factor Influencing Breast Surgery Type Decision-Making

Completed
NCT02789657Phase 2

Neoadjuvant Therapy in Clinical Stage I-III HER2-positive Breast Cancer.

Completed
NCT02907918Phase 2

Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer

Terminated
NCT02376413

Oncoplastic Breast-conserving Surgery in Non-metastatic Breast Cancer Patients

Withdrawn
NCT01396993

Prospective Non-randomized Evaluation of Oncoplastic Surgery

Unknown

All 16 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
16